
Shotsy
Mobile app designed to empower users of GLP-1 medications by providing a comprehensive tracking tool for managing their treatment journey.
Date | Investors | Amount | Round |
---|---|---|---|
* | $2.3m | Seed | |
Total Funding | 000k |
Related Content
Shotsy is a specialized application designed for users of GLP-1 medications, providing a comprehensive platform to track and optimize their health journey. The app caters to individuals managing their treatment with GLP-1 medications, often used for weight management and cardiovascular health. Shotsy allows users to log their weekly injections, monitor side effects, and track progress with ease. The platform supports users in maintaining a detailed record of their health metrics, including weight, protein intake, water consumption, and calorie tracking, all in one place. By syncing data, users can effortlessly observe trends and adjust their health goals accordingly. The business model likely revolves around app subscriptions or in-app purchases, targeting a niche market of health-conscious individuals seeking to enhance their treatment outcomes. Shotsy stands out by offering a user-friendly interface that simplifies the management of complex health data, making it an essential tool for those on GLP-1 medications.
Keywords: GLP-1, medication, tracking, health, injections, weight management, cardiovascular, data logging, progress, app.